|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
13 |
11/03/21 |
| 11/03/21 |
Charts
|
5.9K
|
2.3M
|
13
|
|
|
ASX - By Stock
|
PER |
Re:
Sarepta gene therapy study missed key target in Duchennes
|
|
Vinceanna
|
413 |
166K |
19 |
11/03/21 |
| 11/03/21 |
ASX - By Stock
|
413
|
166K
|
19
|
|
|
ASX - By Stock
|
PER |
Re:
Could the immune system be key to Alzheimer’s disease?
|
|
Vinceanna
|
14 |
10K |
11 |
08/03/21 |
| 08/03/21 |
ASX - By Stock
|
14
|
10K
|
11
|
|
|
ASX - By Stock
|
PER |
Re:
Ann: FDA Rare Disease Day 2021
|
|
Vinceanna
|
31 |
13K |
5 |
06/03/21 |
| 06/03/21 |
ASX - By Stock
|
31
|
13K
|
5
|
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
3 |
19/02/21 |
| 19/02/21 |
Charts
|
5.9K
|
2.3M
|
3
|
|
|
Charts
|
PER |
Re:
Chart
|
|
Vinceanna
|
5.9K |
2.3M |
5 |
19/02/21 |
| 19/02/21 |
Charts
|
5.9K
|
2.3M
|
5
|
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives $801,738 R&D tax incentive refund and grant
|
|
Vinceanna
|
76 |
25K |
3 |
04/02/21 |
| 04/02/21 |
ASX - By Stock
|
76
|
25K
|
3
|
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Vinceanna
|
314 |
82K |
0 |
31/01/21 |
| 31/01/21 |
ASX - By Stock
|
314
|
82K
|
0
|
|
|
ASX - By Stock
|
PER |
Re:
Anp getting traction in the USA.
|
|
Vinceanna
|
10 |
5.0K |
2 |
20/01/21 |
| 20/01/21 |
ASX - By Stock
|
10
|
5.0K
|
2
|
|
|
ASX - By Stock
|
DXB |
Re:
Any reason for today's pump?
|
|
Vinceanna
|
60 |
20K |
5 |
23/12/20 |
| 23/12/20 |
ASX - By Stock
|
60
|
20K
|
5
|
|